EXOZ EXOZ Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price at other companies

KopinKOPN

$3.21—

BTCSBTCS

$2.64+6.9%

Norwood FinancialNWFL

$7.56+0.3%

Alpha CognitionACOG

$5.90—

CTO

Citius Oncology, Inc.CTOR

$0.80—

MMT

Miluna Acquisition MMTX

$11.50—

Other financials

Income statement

See full

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

See full

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

See full

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

See full

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

See full

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

See full

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's share based compensation arrangement by share based payment award fair value assumptions exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EXOZ's share based compensation arrangement by share based payment award fair value assumptions exercise price?: EXOZ (EXOZ) reported share based compensation arrangement by share based payment award fair value assumptions exercise price of $9.49 in Q1 2026.